nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1D—autistic disorder	0.359	0.452	CbGaD
Naratriptan—MAOA—autistic disorder	0.223	0.281	CbGaD
Naratriptan—HTR1B—autistic disorder	0.213	0.268	CbGaD
Naratriptan—HTR1B—telencephalic ventricle—autistic disorder	0.00584	0.0891	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—autistic disorder	0.00566	0.0862	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—autistic disorder	0.00472	0.0719	CbGeAlD
Naratriptan—HTR1F—forebrain—autistic disorder	0.00373	0.0568	CbGeAlD
Naratriptan—HTR1F—telencephalon—autistic disorder	0.00343	0.0522	CbGeAlD
Naratriptan—HTR1A—hindbrain—autistic disorder	0.00223	0.0339	CbGeAlD
Naratriptan—HTR1F—head—autistic disorder	0.00213	0.0325	CbGeAlD
Naratriptan—MAOA—hindbrain—autistic disorder	0.00203	0.031	CbGeAlD
Naratriptan—HTR1F—nervous system—autistic disorder	0.00202	0.0308	CbGeAlD
Naratriptan—HTR1F—central nervous system—autistic disorder	0.00195	0.0297	CbGeAlD
Naratriptan—HTR1B—brainstem—autistic disorder	0.00158	0.0241	CbGeAlD
Naratriptan—HTR1F—brain—autistic disorder	0.00155	0.0236	CbGeAlD
Naratriptan—HTR1D—brainstem—autistic disorder	0.00153	0.0233	CbGeAlD
Naratriptan—HTR1B—forebrain—autistic disorder	0.00153	0.0233	CbGeAlD
Naratriptan—HTR1D—eye—autistic disorder	0.00149	0.0227	CbGeAlD
Naratriptan—HTR1D—forebrain—autistic disorder	0.00148	0.0225	CbGeAlD
Naratriptan—HTR1B—telencephalon—autistic disorder	0.0014	0.0214	CbGeAlD
Naratriptan—HTR1D—telencephalon—autistic disorder	0.00136	0.0207	CbGeAlD
Naratriptan—HTR1A—brainstem—autistic disorder	0.00128	0.0194	CbGeAlD
Naratriptan—HTR1A—forebrain—autistic disorder	0.00123	0.0188	CbGeAlD
Naratriptan—MAOA—brainstem—autistic disorder	0.00117	0.0178	CbGeAlD
Naratriptan—HTR1A—telencephalon—autistic disorder	0.00113	0.0173	CbGeAlD
Naratriptan—MAOA—forebrain—autistic disorder	0.00113	0.0171	CbGeAlD
Naratriptan—MAOA—telencephalon—autistic disorder	0.00103	0.0158	CbGeAlD
Naratriptan—Almotriptan—HTR1D—autistic disorder	0.000984	0.152	CrCbGaD
Naratriptan—Sumatriptan—HTR3A—autistic disorder	0.000958	0.148	CrCbGaD
Naratriptan—Sumatriptan—HTR1D—autistic disorder	0.000947	0.147	CrCbGaD
Naratriptan—HTR1B—head—autistic disorder	0.000874	0.0133	CbGeAlD
Naratriptan—HTR1D—head—autistic disorder	0.000846	0.0129	CbGeAlD
Naratriptan—HTR1B—nervous system—autistic disorder	0.000829	0.0126	CbGeAlD
Naratriptan—HTR1D—nervous system—autistic disorder	0.000802	0.0122	CbGeAlD
Naratriptan—HTR1B—central nervous system—autistic disorder	0.000798	0.0122	CbGeAlD
Naratriptan—MAOA—digestive system—autistic disorder	0.00079	0.012	CbGeAlD
Naratriptan—HTR1D—central nervous system—autistic disorder	0.000772	0.0118	CbGeAlD
Naratriptan—Eletriptan—HTR1D—autistic disorder	0.000767	0.119	CrCbGaD
Naratriptan—HTR1A—head—autistic disorder	0.000705	0.0107	CbGeAlD
Naratriptan—HTR1A—nervous system—autistic disorder	0.000669	0.0102	CbGeAlD
Naratriptan—MAOA—head—autistic disorder	0.000644	0.00982	CbGeAlD
Naratriptan—HTR1A—central nervous system—autistic disorder	0.000644	0.00981	CbGeAlD
Naratriptan—HTR1B—brain—autistic disorder	0.000633	0.00965	CbGeAlD
Naratriptan—HTR1A—cerebellum—autistic disorder	0.000629	0.00959	CbGeAlD
Naratriptan—HTR1D—brain—autistic disorder	0.000613	0.00934	CbGeAlD
Naratriptan—Almotriptan—MAOA—autistic disorder	0.000611	0.0947	CrCbGaD
Naratriptan—MAOA—nervous system—autistic disorder	0.000611	0.00931	CbGeAlD
Naratriptan—Sumatriptan—MAOA—autistic disorder	0.000589	0.0912	CrCbGaD
Naratriptan—MAOA—central nervous system—autistic disorder	0.000588	0.00896	CbGeAlD
Naratriptan—Almotriptan—HTR1B—autistic disorder	0.000584	0.0904	CrCbGaD
Naratriptan—MAOA—cerebellum—autistic disorder	0.000575	0.00876	CbGeAlD
Naratriptan—Sumatriptan—HTR1B—autistic disorder	0.000562	0.087	CrCbGaD
Naratriptan—HTR1A—brain—autistic disorder	0.000511	0.00779	CbGeAlD
Naratriptan—MAOA—brain—autistic disorder	0.000467	0.00712	CbGeAlD
Naratriptan—Eletriptan—HTR1B—autistic disorder	0.000455	0.0704	CrCbGaD
Naratriptan—HTR1D—Signaling Pathways—AVPR1A—autistic disorder	2.54e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADRB2—autistic disorder	2.51e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—autistic disorder	2.5e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PRKCB—autistic disorder	2.49e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AVPR1A—autistic disorder	2.49e-05	0.000187	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—autistic disorder	2.47e-05	0.000186	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MAOB—autistic disorder	2.47e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GRM5—autistic disorder	2.46e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VIP—autistic disorder	2.46e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD1—autistic disorder	2.43e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AVP—autistic disorder	2.4e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GRM5—autistic disorder	2.4e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VIP—autistic disorder	2.4e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CG—autistic disorder	2.38e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OXTR—autistic disorder	2.38e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OXT—autistic disorder	2.38e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR1B—autistic disorder	2.38e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—DRD3—autistic disorder	2.36e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AVP—autistic disorder	2.35e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SCT—autistic disorder	2.35e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OXTR—autistic disorder	2.33e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADRB2—autistic disorder	2.32e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR1D—autistic disorder	2.32e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL5—autistic disorder	2.31e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SCT—autistic disorder	2.31e-05	0.000173	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TPH2—autistic disorder	2.3e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CALCA—autistic disorder	2.28e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADRB2—autistic disorder	2.28e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—autistic disorder	2.27e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRL—autistic disorder	2.26e-05	0.00017	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DPYD—autistic disorder	2.26e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADM—autistic disorder	2.25e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GABBR1—autistic disorder	2.25e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRLR—autistic disorder	2.23e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD1—autistic disorder	2.21e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EIF4E—autistic disorder	2.21e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADM—autistic disorder	2.2e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GABBR1—autistic disorder	2.2e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDE4B—autistic disorder	2.19e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AVP—autistic disorder	2.18e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EIF4E—autistic disorder	2.16e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRM8—autistic disorder	2.15e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADRB2—autistic disorder	2.15e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDE4B—autistic disorder	2.14e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—DRD3—autistic disorder	2.14e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AVP—autistic disorder	2.14e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OPRM1—autistic disorder	2.12e-05	0.000159	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—HRAS—autistic disorder	2.12e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—autistic disorder	2.11e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—autistic disorder	2.1e-05	0.000158	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNA1C—autistic disorder	2.1e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL5—autistic disorder	2.09e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WNT2—autistic disorder	2.09e-05	0.000157	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OPRM1—autistic disorder	2.08e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALCA—autistic disorder	2.07e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GHR—autistic disorder	2.06e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PLA2G4A—autistic disorder	2.05e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDE4A—autistic disorder	2.03e-05	0.000152	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—MAPK1—autistic disorder	2.02e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AVP—autistic disorder	2.02e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PLA2G4A—autistic disorder	2.01e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF2—autistic disorder	2.01e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—autistic disorder	2e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—autistic disorder	1.96e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GZMB—autistic disorder	1.94e-05	0.000146	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DHFR—autistic disorder	1.91e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADRB2—autistic disorder	1.91e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GZMB—autistic disorder	1.9e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVPR1A—autistic disorder	1.9e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PLA2G4A—autistic disorder	1.9e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OXT—autistic disorder	1.88e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1B—autistic disorder	1.88e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2—autistic disorder	1.85e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MEF2C—autistic disorder	1.84e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OXT—autistic disorder	1.84e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRM5—autistic disorder	1.83e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VIP—autistic disorder	1.83e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—autistic disorder	1.82e-05	0.000137	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ITGB3—autistic disorder	1.8e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AVP—autistic disorder	1.79e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—autistic disorder	1.78e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OXTR—autistic disorder	1.77e-05	0.000133	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SCT—autistic disorder	1.76e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PRKCB—autistic disorder	1.75e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSC1—autistic disorder	1.75e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD1—autistic disorder	1.75e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADRB2—autistic disorder	1.73e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PRKCB—autistic disorder	1.72e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSC1—autistic disorder	1.71e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD1—autistic disorder	1.71e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK2—autistic disorder	1.7e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DRD3—autistic disorder	1.69e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CG—autistic disorder	1.68e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—autistic disorder	1.68e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2—autistic disorder	1.68e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADM—autistic disorder	1.68e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GABBR1—autistic disorder	1.68e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK2—autistic disorder	1.67e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DRD3—autistic disorder	1.66e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL5—autistic disorder	1.66e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EIF4E—autistic disorder	1.65e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CG—autistic disorder	1.64e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALCA—autistic disorder	1.64e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDE4B—autistic disorder	1.63e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AVP—autistic disorder	1.63e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL5—autistic disorder	1.62e-05	0.000122	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—HRAS—autistic disorder	1.62e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCA—autistic disorder	1.6e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—autistic disorder	1.6e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TSC2—autistic disorder	1.59e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCB—autistic disorder	1.59e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPRM1—autistic disorder	1.58e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—autistic disorder	1.56e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LEP—autistic disorder	1.56e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—autistic disorder	1.56e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCB—autistic disorder	1.56e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PLA2G4A—autistic disorder	1.53e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CG—autistic disorder	1.52e-05	0.000115	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP19A1—autistic disorder	1.5e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CG—autistic disorder	1.49e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—autistic disorder	1.49e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCB—autistic disorder	1.47e-05	0.000111	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—autistic disorder	1.45e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRL—autistic disorder	1.45e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GZMB—autistic disorder	1.45e-05	0.000109	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—autistic disorder	1.42e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRL—autistic disorder	1.42e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APC—autistic disorder	1.41e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CG—autistic disorder	1.41e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OXT—autistic disorder	1.4e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR1B—autistic disorder	1.4e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGF—autistic disorder	1.39e-05	0.000105	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—COMT—autistic disorder	1.39e-05	0.000105	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTP1—autistic disorder	1.38e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRB2—autistic disorder	1.37e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—autistic disorder	1.36e-05	0.000102	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAT—autistic disorder	1.35e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRB2—autistic disorder	1.34e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—autistic disorder	1.34e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCB—autistic disorder	1.31e-05	9.84e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSC1—autistic disorder	1.31e-05	9.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD1—autistic disorder	1.31e-05	9.82e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AVP—autistic disorder	1.29e-05	9.7e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—autistic disorder	1.29e-05	9.7e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—autistic disorder	1.28e-05	9.66e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—MAPK1—autistic disorder	1.28e-05	9.65e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLA2G4A—autistic disorder	1.27e-05	9.57e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTM1—autistic disorder	1.27e-05	9.57e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—autistic disorder	1.27e-05	9.55e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD3—autistic disorder	1.26e-05	9.51e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AVP—autistic disorder	1.26e-05	9.5e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—autistic disorder	1.26e-05	9.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CG—autistic disorder	1.25e-05	9.42e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL5—autistic disorder	1.24e-05	9.31e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SERPINE1—autistic disorder	1.22e-05	9.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCA—autistic disorder	1.22e-05	9.19e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—autistic disorder	1.22e-05	9.17e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PLA2G4A—autistic disorder	1.21e-05	9.12e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—autistic disorder	1.19e-05	8.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCB—autistic disorder	1.19e-05	8.94e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PLA2G4A—autistic disorder	1.19e-05	8.93e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—autistic disorder	1.18e-05	8.89e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MEF2C—autistic disorder	1.18e-05	8.87e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—autistic disorder	1.16e-05	8.7e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MEF2C—autistic disorder	1.16e-05	8.69e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ITGB3—autistic disorder	1.15e-05	8.65e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CG—autistic disorder	1.14e-05	8.55e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ITGB3—autistic disorder	1.13e-05	8.47e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—autistic disorder	1.12e-05	8.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—autistic disorder	1.08e-05	8.14e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRL—autistic disorder	1.08e-05	8.12e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—autistic disorder	1.07e-05	8.07e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—autistic disorder	1.07e-05	8.07e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—autistic disorder	1.05e-05	7.91e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—autistic disorder	1.05e-05	7.9e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—autistic disorder	1.05e-05	7.88e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRAS—autistic disorder	1.03e-05	7.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB2—autistic disorder	1.02e-05	7.7e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSC2—autistic disorder	1.02e-05	7.67e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSC2—autistic disorder	9.98e-06	7.51e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—autistic disorder	9.98e-06	7.51e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—autistic disorder	9.98e-06	7.51e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—autistic disorder	9.91e-06	7.45e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—autistic disorder	9.86e-06	7.42e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—autistic disorder	9.77e-06	7.35e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—autistic disorder	9.77e-06	7.35e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—autistic disorder	9.62e-06	7.24e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—autistic disorder	9.58e-06	7.21e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—autistic disorder	9.45e-06	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—autistic disorder	9.41e-06	7.08e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—autistic disorder	9.32e-06	7.01e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—autistic disorder	9.21e-06	6.93e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	9.05e-06	6.8e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—autistic disorder	9.01e-06	6.77e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APC—autistic disorder	9.01e-06	6.77e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—autistic disorder	9e-06	6.77e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGF—autistic disorder	8.9e-06	6.7e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APC—autistic disorder	8.82e-06	6.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—autistic disorder	8.82e-06	6.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—autistic disorder	8.81e-06	6.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MEF2C—autistic disorder	8.8e-06	6.62e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGF—autistic disorder	8.72e-06	6.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ITGB3—autistic disorder	8.58e-06	6.45e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—autistic disorder	8.57e-06	6.45e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—autistic disorder	8.39e-06	6.31e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—autistic disorder	8.25e-06	6.2e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK1—autistic disorder	8.21e-06	6.17e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—autistic disorder	8.07e-06	6.07e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK1—autistic disorder	8.04e-06	6.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—autistic disorder	8.01e-06	6.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—autistic disorder	8e-06	6.02e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—autistic disorder	7.83e-06	5.89e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—autistic disorder	7.67e-06	5.77e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSC2—autistic disorder	7.61e-06	5.72e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK1—autistic disorder	7.58e-06	5.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—autistic disorder	7.44e-06	5.6e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—autistic disorder	7.44e-06	5.6e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—autistic disorder	7.18e-06	5.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—autistic disorder	7.02e-06	5.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APC—autistic disorder	6.72e-06	5.05e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	6.72e-06	5.05e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGF—autistic disorder	6.64e-06	4.99e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRAS—autistic disorder	6.59e-06	4.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRAS—autistic disorder	6.45e-06	4.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—autistic disorder	6.39e-06	4.81e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—autistic disorder	6.34e-06	4.77e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—autistic disorder	6.31e-06	4.74e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—autistic disorder	6.26e-06	4.71e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—autistic disorder	6.21e-06	4.67e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—autistic disorder	6.17e-06	4.64e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—autistic disorder	6.15e-06	4.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	6.12e-06	4.6e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRAS—autistic disorder	6.09e-06	4.58e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—autistic disorder	5.96e-06	4.49e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	5.84e-06	4.39e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—autistic disorder	5.84e-06	4.39e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—autistic disorder	5.82e-06	4.38e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRAS—autistic disorder	4.91e-06	3.7e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK1—autistic disorder	4.85e-06	3.65e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK1—autistic disorder	4.75e-06	3.57e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—autistic disorder	4.73e-06	3.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—autistic disorder	4.7e-06	3.54e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—autistic disorder	4.45e-06	3.35e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRAS—autistic disorder	3.89e-06	2.93e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRAS—autistic disorder	3.81e-06	2.87e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—autistic disorder	3.72e-06	2.8e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—autistic disorder	3.65e-06	2.74e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK1—autistic disorder	3.62e-06	2.72e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRAS—autistic disorder	2.9e-06	2.18e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—autistic disorder	2.78e-06	2.09e-05	CbGpPWpGaD
